Balchem Corp BCPC Stock Analysis
- Nasdaq
- Stock
- Market open · no trades yet today
$179.71 down $2.87, 1.57% at close Nov 5
Last close · Previous close $182.58
- Market cap
- At the Nov 5 close
- P/E ratio
- 33.84On last 12 months’ EPS
- Diluted EPS
- $5.31Last 12 months
- Dividend yield
- 0.53%Last 12 months
Price chart
$179.71down $2.87, 1.57%Thu, Nov 5 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$182.58Nov 4
- Volume543.22KNov 5 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume322.79KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $147.18 to $186.15; now $179.71
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 5 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
BCPC beat the S&P 500 in 4 of 7 periods.
| Period | BCPC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | BCPC: up 8.2% S&P 500: down 5.4% | BCPC beat the S&P 500 by 13.6 percentage points Beat |
| 3M | BCPC: up 0.5% S&P 500: down 4.5% | BCPC beat the S&P 500 by 5.0 percentage points Beat |
| YTD | BCPC: up 17.2% S&P 500: up 8.3% | BCPC beat the S&P 500 by 8.9 percentage points Beat |
| 1Y | BCPC: up 18.4% S&P 500: up 9.3% | BCPC beat the S&P 500 by 9.1 percentage points Beat |
| Long term | ||
| 3Y | BCPC: up 51.4% S&P 500: up 74.8% +14.8% vs +20.5% a year | BCPC trailed the S&P 500 by 23.4 percentage points Trailed |
| 5Y | BCPC: up 14.3% S&P 500: up 67.3% +2.7% vs +10.8% a year | BCPC trailed the S&P 500 by 53.0 percentage points Trailed |
| 10Y | BCPC: up 169.8% S&P 500: up 311.8% +10.4% vs +15.2% a year | BCPC trailed the S&P 500 by 142.0 percentage points Trailed |
$10,000 invested in BCPC 10 years ago (Nov 4, 2016) would be worth about $26,976 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,184.
BCPC beat the S&P 500 in 4 of 7 periods.
| Period | BCPC and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | BCPC: up 8.2% S&P 500: down 5.4% | BCPC beat the S&P 500 by 13.6 percentage points Beat |
| 3M | BCPC: up 0.5% S&P 500: down 4.8% | BCPC beat the S&P 500 by 5.3 percentage points Beat |
| YTD | BCPC: up 17.2% S&P 500: up 7.5% | BCPC beat the S&P 500 by 9.7 percentage points Beat |
| 1Y | BCPC: up 17.7% S&P 500: up 8.2% | BCPC beat the S&P 500 by 9.5 percentage points Beat |
| Long term | ||
| 3Y | BCPC: up 48.5% S&P 500: up 68.6% +14.1% vs +19.0% a year | BCPC trailed the S&P 500 by 20.1 percentage points Trailed |
| 5Y | BCPC: up 11.0% S&P 500: up 56.4% +2.1% vs +9.4% a year | BCPC trailed the S&P 500 by 45.4 percentage points Trailed |
| 10Y | BCPC: up 155.2% S&P 500: up 251.5% +9.8% vs +13.4% a year | BCPC trailed the S&P 500 by 96.3 percentage points Trailed |
$10,000 invested in BCPC 10 years ago (Nov 4, 2016) would be worth about $25,520 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,147.
All-time high
$183.41
Closing high on . Now 2.0% below that record.
Split-adjusted daily closes since Jun 3, 1986.
Stock splits
7
Latest: 3-for-2 on . One share bought before the first split is 13 shares today.
All 7 splits
- 3-for-2
- 3-for-2
- 3-for-2
- 3-for-2
- 3-for-2
- 4-for-3
- 5-for-4
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q3 FY26, the quarter ended Sep 30, 2026. “Last 12 months” means the four quarters from Oct 1, 2025 to Sep 30, 2026, and balance-sheet figures are as of Sep 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $1.11Bup 9.4%
- Net income
- $170.85Mup 14.5%
- Diluted EPS
- $5.31up 16.2%
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY24 (Dec 31, 2024) | $240.00M | $33.58M | $1.03 |
| Q1 FY25 (Mar 31, 2025) | $250.52M | $37.05M | $1.13 |
| Q2 FY25 (Jun 30, 2025) | $255.47M | $38.28M | $1.17 |
| Q3 FY25 (Sep 30, 2025) | $267.56M | $40.29M | $1.24 |
| Q4 FY25 (Dec 31, 2025) | $263.62M | $39.23M | $1.21 |
| Q1 FY26 (Mar 31, 2026) | $270.71M | $40.29M | $1.25 |
| Q2 FY26 (Jun 30, 2026) | $284.00M | $44.62M | $1.39 |
| Q3 FY26 (Sep 30, 2026) | $290.66M | $46.73M | $1.46 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $799.02M | $96.10M | $2.94 |
| FY22 (Dec 31, 2022) | $942.36M | $105.37M | $3.25 |
| FY23 (Dec 31, 2023) | $922.44M | $108.54M | $3.35 |
| FY24 (Dec 31, 2024) | $953.68M | $128.48M | $3.93 |
| FY25 (Dec 31, 2025) | $1.04B | $154.85M | $4.75 |
Margins
- Gross 36.5%
- Operating 20.7%
- Net 15.4%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $178.01MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$223.82MLast 12 months
- Capital spending$45.81MLast 12 months
- 16.1%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $111.52MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$30.78MLast 12 months
- Total returned$142.31MLast 12 months
80% of free cash flow
Balance sheet
- $66.26MAs of Sep 30, 2026
Cash plus short- and long-term marketable securities on the Sep 30, 2026 balance sheet.
- Total debt$142.44MAs of Sep 30, 2026
- Net debt$76.18MAs of Sep 30, 2026
- 2.47As of Sep 30, 2026
Current assets divided by current liabilities on the Sep 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.11As of Sep 30, 2026
Total debt divided by shareholders’ equity on the Sep 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 8 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✓Operating cash flow was positive: passed
- ✓Return on assets improved: passed
- ✓Operating cash flow exceeded net income: passed
- ✓Long-term debt fell relative to assets: passed
- ✗Current ratio improved: not passed
- ✓Share count didn’t rise: passed
- ✓Gross margin improved: passed
- ✓Asset turnover (revenue ÷ assets) improved: passed
- 13.2%Last 12 months
Over the last 12 months, Balchem’s net income was 13.2% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 10.1%Last 12 months
Over the last 12 months, Balchem’s net income was 10.1% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $0.38 |
| 2017 | $0.42 |
| 2018 | $0.47 |
| 2019 | $0.52 |
| 2020 | $0.58 |
| 2021 | $0.64 |
| 2022 | $0.71 |
| 2023 | $1.19 |
| 2024 | $0.87 |
| 2025 | $0.96 |
| 2026 (to date) | $0.000 |
Dividend details
- $0.96Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- Dividend yield0.53%Last 12 months
- $0.96Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
- FrequencyAnnual1 payment in the last 12 months
- up 10.6% a yearFull years 2020–2025
The compound annual growth rate of the full-year dividend per share from 2020 to 2025.
- 16 yearsThrough 2025
How many calendar years in a row the full-year amount has risen, through 2025.
- 18.1%Last 12 months
The share of earnings paid out as dividends over the last 12 months. Lower ratios leave more room to reinvest or raise the dividend.
Payout = Dividends per share ÷ Diluted EPS (both last 12 months)Payout ratio calculator
About Balchem Corp
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. Contact: Jacqueline Yarmolowicz Balchem Corporation (Telephone: 845-326-5600)
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Headquarters
- New York, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
BCPC news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
BCPC stock FAQ
What is BCPC stock’s price today?
Balchem (BCPC) traded at $179.71 at the close on , down $2.87 (1.57%) from the previous close of $182.58. Over the past 52 weeks it has traded between $147.18 and $186.15.
If you invested $1,000 in BCPC 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in BCPC on would be worth about $2,698 at the close on , a total return of +169.8%. The same $1,000 would be worth $1,143 if invested five years ago, $1,184 if invested one year ago, $20,314 if invested 20 years ago, and $187,860 if invested 30 years ago. Past performance doesn’t predict future returns.
What is BCPC’s P/E ratio?
BCPC trades at 33.8 times its diluted earnings over the four quarters to ($5.31 per share), at the close. (How the P/E ratio works.)
How much revenue does Balchem make?
Balchem reported $1.1 billion of revenue over the four quarters to , up 9.4% from the twelve months before. In its latest quarter (Q3 FY26, ended ) revenue was $290.7 million, up 8.6% from a year earlier.
Is Balchem profitable?
Yes. Balchem earned $170.9 million of net income over the four quarters to , a net margin of 15.4%, and its operating margin was 20.7% (what margins tell you).
What are BCPC’s earnings per share?
BCPC’s diluted earnings per share were $5.31 over the four quarters to , compared with $4.57 in the twelve months before. The latest quarter (Q3 FY26) brought $1.46 per share, against $1.24 a year earlier (how EPS works).
Does BCPC pay a dividend?
Yes. Balchem pays a annual dividend. The most recent was $0.96 per share, with an ex-dividend date of . Over the last twelve months it paid $0.96 per share, a 0.53% yield at the close, and the full-year dividend has risen 16 years in a row (how dividend yield works).
Based on the last 12 months’ payments ($0.96 per share), and if the next 12 months match the last 12, 100 shares would receive about $96 over 12 months, and $1,000 over 12 months would take about 1,042 shares, roughly $187,258 at the close. Dividends can change.
What is BCPC’s 52-week high and low?
Over the past 52 weeks BCPC has traded as low as $147.18 and as high as $186.15. At $179.71 at the close on , it is 3.5% below that high and 22.1% above the low.
What is BCPC’s all-time high?
BCPC’s highest closing price was $183.41 on , adjusted for stock splits. At $179.71 at the close on , it is 2.0% below that record.
Has BCPC stock ever split?
Yes, seven times: 5-for-4 on ; 4-for-3 on ; 3-for-2 on ; 3-for-2 on ; 3-for-2 on ; 3-for-2 on ; 3-for-2 on . One share bought before the first split would be 13 shares today.
How has BCPC stock performed?
Including dividends and measured to the close on , BCPC has returned +17.2% so far this year and +18.4% over the past year, and +14.3% over five years (+2.7% a year). Over the same periods the S&P 500, measured by SPY, returned +8.3%, +9.3% and +67.3%. Past performance doesn’t predict future returns.
What sector and industry is Balchem in?
Balchem is in the Basic Materials sector and the Specialty Chemicals industry, and is headquartered in New York, USA.
What exchange does BCPC trade on?
Balchem trades on the Nasdaq under the ticker symbol BCPC. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.